ClearPoint Neuro
CLPT
62 hedge funds and large institutions have $36M invested in ClearPoint Neuro in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 9 closing their positions.
152% more call options, than puts
Call options by funds: $1.03M | Put options by funds: $410K
67% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 9
43% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 14
11% more funds holding
Funds holding: 56 → 62 (+6)
1.62% more ownership
Funds ownership: 15.62% → 17.24% (+1.6%)
9% less capital invested
Capital invested by funds: $39.6M → $36M (-$3.61M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$985K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$930K |
| 3 |
Citigroup
New York
|
+$667K |
| 4 |
LCM
Legato Capital Management
San Francisco,
California
|
+$593K |
| 5 |
SL
Sentinus LLC
Oak Brook,
Illinois
|
+$585K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$1.17M |
| 2 |
E
Ergoteles
New York
|
-$739K |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$528K |
| 4 |
CCM
Conway Capital Management
Burbank,
California
|
-$466K |
| 5 |
SAF
Smith Anglin Financial
Dallas,
Texas
|
-$207K |
CLPT Hedge Fund Activity: Q4 2022 in Review
62 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q4 2022, worth a combined $36M — down 9.1% from $39.6M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new CLPT positions and 9 closed out — a net gain of 6 holders — while 20 added to existing stakes and 14 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $985K. The largest seller was EAM Investors, exiting entirely with an estimated $1.17M sold.
- 62 institutional investors held ClearPoint Neuro (CLPT) as of Q4 2022, up from 56 in Q3 2022.
- Funds reported $36M of ClearPoint Neuro stock for Q4 2022, down 9.1% quarter-over-quarter.
- 15 funds opened new ClearPoint Neuro positions in Q4 2022 and 9 closed out, a net change of +6 holders.
- The largest ClearPoint Neuro buyer in Q4 2022 was Susquehanna International Group, an estimated $985K added.
- The largest ClearPoint Neuro seller in Q4 2022 was EAM Investors, an estimated $1.17M sold.
Based on aggregated 13F filings for Q4 2022.